All News #Library
Others
Cantex Pharma: Four Azeliragon Abstracts At ASCO 2024 Annual Meeting
28 May 2024 //
PR NEWSWIRE
Cantex & Michigan Announce Initiation Of Phase 3 Trial To Evaluate Azeliragon
27 Sep 2023 //
PR NEWSWIRE
Cantex and Allegheny Health Announce Initiation of a Phase 1/2 of Azeliragon
26 Sep 2023 //
PR NEWSWIRE
Cantex Announces Initiation of Invg-Initiated Ph2 Trial Investigating Azeliragon
28 Aug 2023 //
PR NEWSWIRE
Cantex Announces Article Published in npj Highlighting Role of RAGE Inhibition
10 Aug 2023 //
PR NEWSWIRE
Cantex To Present At The Medinvest Oncology Investor Conference In Boston
15 Jun 2023 //
PR NEWSWIRE
Cantex Obtains Exclusive Worldwide Rights To Intellectual Property
01 Jun 2023 //
PR NEWSWIRE
Cantex & Michigan Medicine Announce Initiation Ph 2/3 Clinical Study Azeliragon
20 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support